The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of cyclooxygenase inhibition on CXCR3 ligand secretion in breast cancer.
H. Bronger
No relevant relationships to disclose
S. Kraeft
No relevant relationships to disclose
A. Stöckel
No relevant relationships to disclose
A. Welk
No relevant relationships to disclose
M. Kiechle
No relevant relationships to disclose
M. Schmitt
No relevant relationships to disclose
U. R. M. Schwarz-Boeger
No relevant relationships to disclose